Biography:
Dr. Liu earned her MD from Shanghai Jiao Tong University School of Medicine in China and her PhD from the University of Amsterdam in the Netherlands. She subsequently completed a postdoctoral fellowship at the Royal Netherlands Academy of Arts and Sciences (KNAW).
Dr. Liu has extensive experience in innovative drug development, having held various leadership roles at several global pharmaceutical companies. These include Chairman and CEO at Dendreon (China), General Manager of Medical and Drug Development at Daiichi Sankyo (China), Head of Medical and Regulatory Affairs at Genzyme (China), Medical Head at Novartis Vaccines (China), and Clinical Research Physician at AstraZeneca (China). She currently serves as the CEO of Shanghai Cell Therapy Group Pharmaceutical Technology Inc.
Title : Development of nanobody-armored DC vaccine (BaizeDC) and its preliminary exploration in preventing solid tumor recurrence